Limits...
Reducing TRPC1 Expression through Liposome-Mediated siRNA Delivery Markedly Attenuates Hypoxia-Induced Pulmonary Arterial Hypertension in a Murine Model.

Sun CK, Zhen YY, Lu HI, Sung PH, Chang LT, Tsai TH, Sheu JJ, Chen YL, Chua S, Chang HW, Chen YL, Lee FY, Yip HK - Stem Cells Int (2014)

Bottom Line: By day 28, right ventricular systolic pressure (RVSP), number of muscularized arteries, right ventricle (RV), and lung weights were increased in group 2 than in group 1 and reduced in group 3 compared with group 2.The mRNA expressions of proapoptotic and hypertrophy biomarkers displayed a similar pattern, whereas sarcomere length showed an opposite pattern compared to that of RVSP in all groups.Lipofectamine siRNA delivery effectively reduced TRPC1 expression, thereby attenuating PAH-associated RV and pulmonary arteriolar remodeling.

View Article: PubMed Central - PubMed

Affiliation: Department of Emergency Medicine, E-Da Hospital, I-Shou University College of Medicine, Kaohsiung 82445, Taiwan.

ABSTRACT
We tested the hypothesis that Lipofectamine siRNA delivery to deplete transient receptor potential cation channel (TRPC) 1 protein expression can suppress hypoxia-induced pulmonary arterial hypertension (PAH) in mice. Adult male C57BL/6 mice were equally divided into group 1 (normal controls), group 2 (hypoxia), and group 3 (hypoxia + siRNA TRPC1). By day 28, right ventricular systolic pressure (RVSP), number of muscularized arteries, right ventricle (RV), and lung weights were increased in group 2 than in group 1 and reduced in group 3 compared with group 2. Pulmonary crowded score showed similar pattern, whereas number of alveolar sacs exhibited an opposite pattern compared to that of RVSP in all groups. Protein expressions of TRPCs, HIF-1α, Ku-70, apoptosis, and fibrosis and pulmonary mRNA expressions of inflammatory markers were similar pattern, whereas protein expressions of antifibrosis and VEGF were opposite to the pattern of RVSP. Cellular markers of pulmonary DNA damage, repair, and smooth muscle proliferation exhibited a pattern similar to that of RVSP. The mRNA expressions of proapoptotic and hypertrophy biomarkers displayed a similar pattern, whereas sarcomere length showed an opposite pattern compared to that of RVSP in all groups. Lipofectamine siRNA delivery effectively reduced TRPC1 expression, thereby attenuating PAH-associated RV and pulmonary arteriolar remodeling.

No MeSH data available.


Related in: MedlinePlus

Protein expressions of fibrotic and antifibrotic biomarkers of lung parenchyma by day 28 after hypoxia-induced pulmonary arterial hypertension (PAH) (n = 10). (a) Protein expression of transforming growth factor (TGF-β), ∗ versus other groups with different symbols (∗, †, ‡), P < 0.01. (b) Protein expression of phosphorylated- (P-) Smad3, ∗ versus other groups with different symbols (∗, †, ‡), P < 0.001. (c) Protein expression of bone morphogenetic protein- (BMP-) 2, ∗ versus other groups with different symbols (∗, †, ‡), P < 0.001. (d) Protein expression of phosphorylated- (P-) Smad1/5, ∗ versus other groups with different symbols (∗, †, ‡), P < 0.01. Statistical analysis in ((a) to (d)) using one-way ANOVA, followed by Bonferroni multiple comparison post hoc test. Symbols (∗, †, ‡) indicate significance (at 0.05 level).
© Copyright Policy - open-access
Related In: Results  -  Collection


getmorefigures.php?uid=PMC4281407&req=5

fig8: Protein expressions of fibrotic and antifibrotic biomarkers of lung parenchyma by day 28 after hypoxia-induced pulmonary arterial hypertension (PAH) (n = 10). (a) Protein expression of transforming growth factor (TGF-β), ∗ versus other groups with different symbols (∗, †, ‡), P < 0.01. (b) Protein expression of phosphorylated- (P-) Smad3, ∗ versus other groups with different symbols (∗, †, ‡), P < 0.001. (c) Protein expression of bone morphogenetic protein- (BMP-) 2, ∗ versus other groups with different symbols (∗, †, ‡), P < 0.001. (d) Protein expression of phosphorylated- (P-) Smad1/5, ∗ versus other groups with different symbols (∗, †, ‡), P < 0.01. Statistical analysis in ((a) to (d)) using one-way ANOVA, followed by Bonferroni multiple comparison post hoc test. Symbols (∗, †, ‡) indicate significance (at 0.05 level).

Mentions: The protein expressions of TGF-β and Smad3, two indices of fibrosis, were significantly higher in group 2 than that in groups 1 and 3 and significantly higher in group 3 than that in group 1 (Figures 8(a) and 8(b)). By contrast, the protein expressions of BMP-2 and Smad1/5 (Figures 8(c) and 8(d)), two antifibrotic biomarkers, showed an opposite pattern compared to that of TGF-β and Smad3 among the three groups.


Reducing TRPC1 Expression through Liposome-Mediated siRNA Delivery Markedly Attenuates Hypoxia-Induced Pulmonary Arterial Hypertension in a Murine Model.

Sun CK, Zhen YY, Lu HI, Sung PH, Chang LT, Tsai TH, Sheu JJ, Chen YL, Chua S, Chang HW, Chen YL, Lee FY, Yip HK - Stem Cells Int (2014)

Protein expressions of fibrotic and antifibrotic biomarkers of lung parenchyma by day 28 after hypoxia-induced pulmonary arterial hypertension (PAH) (n = 10). (a) Protein expression of transforming growth factor (TGF-β), ∗ versus other groups with different symbols (∗, †, ‡), P < 0.01. (b) Protein expression of phosphorylated- (P-) Smad3, ∗ versus other groups with different symbols (∗, †, ‡), P < 0.001. (c) Protein expression of bone morphogenetic protein- (BMP-) 2, ∗ versus other groups with different symbols (∗, †, ‡), P < 0.001. (d) Protein expression of phosphorylated- (P-) Smad1/5, ∗ versus other groups with different symbols (∗, †, ‡), P < 0.01. Statistical analysis in ((a) to (d)) using one-way ANOVA, followed by Bonferroni multiple comparison post hoc test. Symbols (∗, †, ‡) indicate significance (at 0.05 level).
© Copyright Policy - open-access
Related In: Results  -  Collection

Show All Figures
getmorefigures.php?uid=PMC4281407&req=5

fig8: Protein expressions of fibrotic and antifibrotic biomarkers of lung parenchyma by day 28 after hypoxia-induced pulmonary arterial hypertension (PAH) (n = 10). (a) Protein expression of transforming growth factor (TGF-β), ∗ versus other groups with different symbols (∗, †, ‡), P < 0.01. (b) Protein expression of phosphorylated- (P-) Smad3, ∗ versus other groups with different symbols (∗, †, ‡), P < 0.001. (c) Protein expression of bone morphogenetic protein- (BMP-) 2, ∗ versus other groups with different symbols (∗, †, ‡), P < 0.001. (d) Protein expression of phosphorylated- (P-) Smad1/5, ∗ versus other groups with different symbols (∗, †, ‡), P < 0.01. Statistical analysis in ((a) to (d)) using one-way ANOVA, followed by Bonferroni multiple comparison post hoc test. Symbols (∗, †, ‡) indicate significance (at 0.05 level).
Mentions: The protein expressions of TGF-β and Smad3, two indices of fibrosis, were significantly higher in group 2 than that in groups 1 and 3 and significantly higher in group 3 than that in group 1 (Figures 8(a) and 8(b)). By contrast, the protein expressions of BMP-2 and Smad1/5 (Figures 8(c) and 8(d)), two antifibrotic biomarkers, showed an opposite pattern compared to that of TGF-β and Smad3 among the three groups.

Bottom Line: By day 28, right ventricular systolic pressure (RVSP), number of muscularized arteries, right ventricle (RV), and lung weights were increased in group 2 than in group 1 and reduced in group 3 compared with group 2.The mRNA expressions of proapoptotic and hypertrophy biomarkers displayed a similar pattern, whereas sarcomere length showed an opposite pattern compared to that of RVSP in all groups.Lipofectamine siRNA delivery effectively reduced TRPC1 expression, thereby attenuating PAH-associated RV and pulmonary arteriolar remodeling.

View Article: PubMed Central - PubMed

Affiliation: Department of Emergency Medicine, E-Da Hospital, I-Shou University College of Medicine, Kaohsiung 82445, Taiwan.

ABSTRACT
We tested the hypothesis that Lipofectamine siRNA delivery to deplete transient receptor potential cation channel (TRPC) 1 protein expression can suppress hypoxia-induced pulmonary arterial hypertension (PAH) in mice. Adult male C57BL/6 mice were equally divided into group 1 (normal controls), group 2 (hypoxia), and group 3 (hypoxia + siRNA TRPC1). By day 28, right ventricular systolic pressure (RVSP), number of muscularized arteries, right ventricle (RV), and lung weights were increased in group 2 than in group 1 and reduced in group 3 compared with group 2. Pulmonary crowded score showed similar pattern, whereas number of alveolar sacs exhibited an opposite pattern compared to that of RVSP in all groups. Protein expressions of TRPCs, HIF-1α, Ku-70, apoptosis, and fibrosis and pulmonary mRNA expressions of inflammatory markers were similar pattern, whereas protein expressions of antifibrosis and VEGF were opposite to the pattern of RVSP. Cellular markers of pulmonary DNA damage, repair, and smooth muscle proliferation exhibited a pattern similar to that of RVSP. The mRNA expressions of proapoptotic and hypertrophy biomarkers displayed a similar pattern, whereas sarcomere length showed an opposite pattern compared to that of RVSP in all groups. Lipofectamine siRNA delivery effectively reduced TRPC1 expression, thereby attenuating PAH-associated RV and pulmonary arteriolar remodeling.

No MeSH data available.


Related in: MedlinePlus